The gene source chain system will create the world's first distributed storage network public chain system that provides genetic data and individual health data. Health and medical providers, including chronic disease management agencies and health counseling providers, can use the Gene Source Chain System to create DApps. These applications will provide users with personalized and accurate health services based on genome and health data, subject to user consent. As a proof of concept, the Gene Source Chain Foundation will also support the creation of a gamified health DApp to help build the ecosystem.
ADN Mainnet is a blockchain-based technology designed to secure ICO investments. Going beyond decentralization, we are pioneers of a built-in investor-oriented mechanism to ensure security and transparency to our investors. ADN aims to transcend into the future of blockchain and ICO with continuous development and innovation. Aiming to provide a tangible solution to existing problems within the industry, we developed a blockchain with high-throughput, high scalability, and high availability for Decentralized Applications (DApps) in the ADN ecosystem. Combining the benefits initially proposed by its cryptocurrency predecessors such as Bitcoin, Ethereum, EOS and TRON, the ADN protocol becomes a high-performance blockchain platform. Integrating the Delegated Proof-of-Stake (dPoS) consensus and ADN Virtual Machine (AVM), it primarily focuses on smart contracts, consensus, and ICO wallet.